PARP1 inhibitor combined with oxaliplatin efficiently suppresses oxaliplatin resistance in gastric cancer-derived organoids via homologous recombination and the base excision repair pathway (vol 9,719192,2021) Artigo Académico uri icon

autores

  • Correia de Oliveira, Joaquim Miguel Antunes
  • Li, Huafu
  • Wang, Chunming
  • Lan, Linxiang
  • Wu, Wenhui
  • Evans, Ian
  • Ruiz, E. Josue
  • Yan, L-P
  • Aksoy-Aksel, A.

data de publicação

  • janeiro 1, 2025